Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC)
Italy · Delayed Price · Currency is EUR 51.45
+0.10 (0.19%)
Jul 27, 2026, 5:36 PM CET
BIT:REC Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 713.42 | 2,618 | 2,342 | 2,082 | 1,853 | 1,580 | |
Revenue Growth | -70.44% | 11.82% | 12.45% | 12.36% | 17.29% | 9.06% |
Cost of Revenue | 812.11 | 830.7 | 741.29 | 659.71 | 566.74 | 427.73 |
Gross Profit | 510.83 | 1,788 | 1,600 | 1,423 | 1,287 | 1,152 |
Selling, General & Admin | 738.36 | 726.99 | 654.38 | 601.11 | 572.16 | 480.89 |
Research & Development | 347.17 | 340.95 | 286.03 | 255.75 | 220.1 | 166.14 |
Other Operating Expenses | 49.56 | 48.93 | 21.01 | 7.76 | 56.98 | 15.13 |
Total Operating Expenses | 1,135 | 1,117 | 961.42 | 864.62 | 849.24 | 662.16 |
Operating Income | 229.6 | 670.81 | 638.86 | 558.01 | 437.33 | 490.19 |
Total Non-Operating Income (Expense) | -20.69 | -89.53 | -91.67 | -66.97 | -35.89 | -26.84 |
Pretax Income | 200.75 | 581.27 | 547.18 | 491.04 | 401.44 | 463.35 |
Provision for Income Taxes | 145.52 | 137.65 | 130.68 | 101.82 | 89.1 | 77.38 |
Net Income | 55.23 | 443.62 | 416.51 | 389.21 | 312.34 | 385.97 |
Net Income to Common | 153.06 | 443.62 | 416.51 | 389.21 | 312.34 | 385.97 |
Net Income Growth | -63.38% | 6.51% | 7.01% | 24.61% | -19.08% | 8.71% |
Shares Outstanding (Basic) | 205 | 205 | 206 | 206 | 206 | 206 |
Shares Outstanding (Diluted) | 205 | 205 | 206 | 206 | 206 | 206 |
Shares Change | -0.70% | -0.40% | 0.33% | 0.03% | -0.21% | 0.12% |
EPS (Basic) | 2.30 | 2.16 | 2.02 | 1.89 | 1.52 | 1.06 |
EPS (Diluted) | 2.25 | 2.12 | 1.99 | 1.86 | 1.49 | 1.05 |
EPS Growth | 12.81% | 6.48% | 7.04% | 24.57% | 42.56% | -38.28% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 490.32 | 557.45 | 533.27 | 455.63 | 437.8 | 469.8 |
Free Cash Flow Growth | -36.19% | 4.54% | 17.04% | 4.07% | -6.81% | 22.88% |
Free Cash Flow Per Share | 2.39 | 2.71 | 2.58 | 2.22 | 2.13 | 2.28 |
Dividends Per Share | 1.340 | 1.340 | 1.270 | 1.200 | 1.150 | 1.100 |
Dividend Growth | 5.51% | 5.51% | 5.83% | 4.35% | 4.54% | 4.76% |
Gross Margin | 71.60% | 68.27% | 68.34% | 68.32% | 69.42% | 72.93% |
Operating Margin | 32.18% | 25.62% | 27.28% | 26.80% | 23.60% | 31.02% |
Profit Margin | 7.74% | 16.94% | 17.79% | 18.69% | 16.85% | 24.43% |
FCF Margin | 68.73% | 21.29% | 22.77% | 21.88% | 23.62% | 29.73% |
EBITDA | 437.58 | 877.24 | 805.88 | 700.68 | 563.08 | 587.78 |
EBITDA Margin | 61.33% | 33.50% | 34.42% | 33.65% | 30.38% | 37.20% |
EBIT | 229.6 | 670.81 | 638.86 | 558.01 | 437.33 | 490.19 |
EBIT Margin | 32.18% | 25.62% | 27.28% | 26.80% | 23.60% | 31.02% |
Effective Tax Rate | 72.49% | 23.68% | 23.88% | 20.74% | 22.20% | 16.70% |